Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$14.88 and traded as low as C$14.35. Cipher Pharmaceuticals shares last traded at C$14.44, with a volume of 39,207 shares traded.
Cipher Pharmaceuticals Stock Down 1.5%
The company has a 50-day simple moving average of C$14.88 and a 200-day simple moving average of C$14.93. The firm has a market cap of C$366.34 million, a PE ratio of 21.55 and a beta of 1.33. The company has a debt-to-equity ratio of 11.75, a current ratio of 1.30 and a quick ratio of 2.67.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.
Further Reading
- Five stocks we like better than Cipher Pharmaceuticals
- The gold chart Wall Street is terrified of…
- “This AI Giant is About to Go Bust”
- I tried out Elon Musk’s new AI tech — it floored me
- Elon Musk’s $1 Quadrillion AI IPO
- Is Trump Done? Shocking leak…
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
